Literature DB >> 5123908

Phenylalanine absorption and metabolism in Parkinsonian patients.

A K Granerus, R Jagenburg, S Rödjer, A Svanborg.   

Abstract

Oral and intravenous L-phenylalanine loading tests were performed in 13 Parkinsonian patients and in 12 control subjects matched for age and weight. The results showed a normal intestinal absorption and a normal elimination from plasma of phenylalanine in the Parkinsonian patients.

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5123908      PMCID： PMC1799570          DOI： 10.1136/bmj.4.5782.262

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


  10 in total

1.  Application of hydrodynamic analog and digital computer to the study of phospholipid kinetics.

Authors:  M L SHORE; R CALLAHAN
Journal:  Ann N Y Acad Sci       Date:  1963-05-10       Impact factor: 5.691

2.  Rapid assay procedures for tritium-labeled water in body fluids.

Authors:  B E VAUGHAN; E A BOLING
Journal:  J Lab Clin Med       Date:  1961-01

3.  A fluorometric method for the estimation of tyrosine in plasma and tissues.

Authors:  T P WAALKES; S UDENFRIEND
Journal:  J Lab Clin Med       Date:  1957-11

4.  Aromatic amino acids and modification of parkinsonism.

Authors:  G C Cotzias; M H Van Woert; L M Schiffer
Journal:  N Engl J Med       Date:  1967-02-16       Impact factor: 91.245

5.  Amino acid and dopa levels in plasma and urine from L-dopa-treated patients with Parkinson's disease.

Authors:  T A Hare; S Vanna; B Beasley; R Chambers; W H Vogel
Journal:  J Lab Clin Med       Date:  1971-02

6.  Oral phenylalanine and tyrosine tolerance tests in Parkinsonian patients.

Authors:  J Braham; I Sarova-Pinhas; M Crispin; R Golan; N Levin; A Szeinberg
Journal:  Br Med J       Date:  1969-05-31

7.  Phenylalanine and tyrosine metabolism in Parkinson's disease treated with levodopa.

Authors:  M H Van Woert
Journal:  Clin Pharmacol Ther       Date:  1971 Mar-Apr       Impact factor: 6.875

8.  Genetics of phenylketonuria. Heterozygosity for phenylketonuria.

Authors:  L I Woolf; W I Cranston; B L Goodwin
Journal:  Nature       Date:  1967-03-04       Impact factor: 49.962

9.  Tolerance of phenylalanine after ntravenous administration in phenylketonurics, heterozygous carriers, and normal adults.

Authors:  H J Bremer; W Neumann
Journal:  Nature       Date:  1966-03-12       Impact factor: 49.962

10.  [The tropical localization and content of noradrenalin and dopamine (3-hydroxytyramine) in the substantia nigra of normal persons and patients with Parkinson's disease].

Authors:  O HORNYKIEWICZ
Journal:  Wien Klin Wochenschr       Date:  1963-05-03       Impact factor: 1.704
  10 in total
  5 in total

1.  Improvement of parkinsonian features correlate with high plasma levodopa values after broad bean (Vicia faba) consumption.

Authors:  J M Rabey; Y Vered; H Shabtai; E Graff; A D Korczyn
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-08       Impact factor: 10.154

Review 2.  Nonlinear pharmacokinetics: clinical Implications.

Authors:  T M Ludden
Journal:  Clin Pharmacokinet       Date:  1991-06       Impact factor: 6.447

Review 3.  Influence of food and diet on gastrointestinal drug absorption: a review.

Authors:  P G Welling
Journal:  J Pharmacokinet Biopharm       Date:  1977-08

4.  Intestinal decarboxylation of L-Dopa in relation to dose requirement in Parkinson's disease.

Authors:  A K Granerus; R Jagenburg; A Svanborg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

5.  Serum amino acid profile in patients with Parkinson's disease.

Authors:  Monika Figura; Katarzyna Kuśmierska; Ewelina Bucior; Stanisław Szlufik; Dariusz Koziorowski; Zygmunt Jamrozik; Piotr Janik
Journal:  PLoS One       Date:  2018-01-29       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.